CytomX Therapeutics
CTMX
CTMX
66 hedge funds and large institutions have $28.8M invested in CytomX Therapeutics in 2025 Q1 according to their latest regulatory filings, with 7 funds opening new positions, 20 increasing their positions, 26 reducing their positions, and 11 closing their positions.
New
Increased
Maintained
Reduced
Closed
less ownership
Funds ownership: →
less funds holding
Funds holding: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less first-time investments, than exits
New positions opened: | Existing positions closed:
40% less capital invested
Capital invested by funds: $48.1M → $28.8M (-$19.3M)
70% less call options, than puts
Call options by funds: $9K | Put options by funds: $30K
Holders
66
Holding in Top 10
–
Calls
$9K
Puts
$30K
Top Buyers
| 1 | +$1.05M | |
| 2 | +$636K | |
| 3 | +$460K | |
| 4 |
Bank of America
Charlotte,
North Carolina
|
+$293K |
| 5 |
UBS Group
Zurich,
Switzerland
|
+$152K |
Top Sellers
| 1 | -$547K | |
| 2 | -$503K | |
| 3 | -$482K | |
| 4 |
JPMorgan Chase & Co
New York
|
-$449K |
| 5 |
TCM
Tang Capital Management
San Diego,
California
|
-$378K |
